Acadia Pharmaceuticals (0A4W.LSE) Q2 2024 Earnings

May 8Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.45
-0.2
0.04
0.29

Details

Expected EPS
0.04881
Actual EPS
0.1
Surprise EPS
0.05
Surprise Percent
+104.88%

Description

⁨Acadia Pharmaceuticals⁩ (⁦0A4W.LSE⁩) has reported earnings of ⁦0.1⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts